-
1
-
-
0025360899
-
Criteria for diagnosis of Behçet's disease
-
International Study Group for Behçet's Disease
-
International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078-1080.
-
(1990)
Lancet.
, vol.335
, pp. 1078-1080
-
-
-
2
-
-
0023959626
-
Revised diagnostic criteria for Behçet's disease in 1987
-
Mizushima Y. Revised diagnostic criteria for Behçet's disease in 1987. Ryumachi. 1988;28:66-70.
-
(1988)
Ryumachi.
, vol.28
, pp. 66-70
-
-
Mizushima, Y.1
-
4
-
-
56249131741
-
Ocular infammation in Behçet disease: Incidence of ocular complications and of loss of visual acuity
-
Kacmaz RO, Kempen JH, Newcomb C, et al. Ocular infammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146:828-836.
-
(2008)
Am J Ophthalmol.
, vol.146
, pp. 828-836
-
-
Kacmaz, R.O.1
Kempen, J.H.2
Newcomb, C.3
-
5
-
-
0033504877
-
Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy
-
Kotake S, Higashi K, Yoshikawa K, et al. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology. 1999;106:586-589. (Pubitemid 30191596)
-
(1999)
Ophthalmology
, vol.106
, Issue.3
, pp. 586-589
-
-
Kotake, S.1
Higashi, K.2
Yoshikawa, K.3
Sasamoto, Y.4
Okamoto, T.5
Matsuda, H.6
-
6
-
-
33746549075
-
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications - Results of a retrospective analysis of 117 cases
-
DOI 10.1007/s10067-005-0070-8
-
Kötter I, Günaydin I, Batra M, et al. CNS involvement occurs more frequently in patients with Behçets disease under cyclosporine A (CSA) than under other medications: results of a retrospective analysis of 117 cases. Clin Rheumatol. 2006;25:482-486. (Pubitemid 44137619)
-
(2006)
Clinical Rheumatology
, vol.25
, Issue.4
, pp. 482-486
-
-
Kotter, I.1
Gunaydin, I.2
Batra, M.3
Vonthein, R.4
Stubiger, N.5
Fierlbeck, G.6
Melms, A.7
-
7
-
-
56749168836
-
EUlAR recommendations for the management of Behçet disease
-
Hatemi G, Silman A, Bang D, et al. EUlAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656-1662.
-
(2008)
Ann Rheum Dis.
, vol.67
, pp. 1656-1662
-
-
Hatemi, G.1
Silman, A.2
Bang, D.3
-
8
-
-
77955327167
-
Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease
-
Deuter CME, Zierhut M, Möhle A, et al. long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum. 2010;62:2796-2805.
-
(2010)
Arthritis Rheum.
, vol.62
, pp. 2796-2805
-
-
Deuter, C.M.E.1
Zierhut, M.2
Möhle, A.3
-
9
-
-
56249121565
-
Long-term effcacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease
-
Gueudry J, Wechsler B, Terrada C, et al. long-term effcacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol. 2008;146:837-844
-
(2008)
Am J Ophthalmol.
, vol.146
, pp. 837-844
-
-
Gueudry, J.1
Wechsler, B.2
Terrada, C.3
-
10
-
-
44349156051
-
Longterm visual prognosis of patients with ocular Adamantiades- Behçet's disease treated with interferon-alpha-2a
-
Krause l, Altenburg A, Pleyer U, et al. long-term visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-α-2a. J Rheumatol. 2008;35:896-903. (Pubitemid 351747134)
-
(2008)
Journal of Rheumatology
, vol.35
, Issue.5
, pp. 896-903
-
-
Krause, L.1
Altenburg, A.2
Pleyer, U.3
Kohler, A.-K.4
Zouboulis, C.C.5
Foerster, M.H.6
-
11
-
-
34347212190
-
Anti-TNF therapy in the management of Behçet's disease - Review and basis for recommendations
-
DOI 10.1093/rheumatology/kem034
-
Sfkakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behçet's disease: review and basis for recommendations. Rheumatology. 2007;46:736-741. (Pubitemid 47061701)
-
(2007)
Rheumatology
, vol.46
, Issue.5
, pp. 736-741
-
-
Sfikakis, P.P.1
Markomichelakis, N.2
Alpsoy, E.3
Assaad-Khalil, S.4
Bodaghi, B.5
Gul, A.6
Ohno, S.7
Pipitone, N.8
Schirmer, M.9
Stanford, M.10
Wechsler, B.11
Zouboulis, C.12
Kaklamanis, P.13
Yazici, H.14
-
12
-
-
3042811083
-
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in behçet's disease with refractory uveoretinitis
-
Ohno S, Nakamura S, Hori S, et al. Effcacy, safety, and phar-macokinetics of multiple administration of infiximab in Behçet's disease with refractory uveoretinitis. J Rheumatol. 2004;31:1362-1368. (Pubitemid 38879203)
-
(2004)
Journal of Rheumatology
, vol.31
, Issue.7
, pp. 1362-1368
-
-
Ohno, S.1
Nakamura, S.2
Hori, S.3
Shimakawa, M.4
Kawashima, H.5
Mochizuki, M.6
Sugita, S.7
Ueno, S.8
Yoshizaki, K.9
Inaba, G.10
|